Survey: Patients with SLE may be more affected by symptoms than physicians perceive

Results of a recent survey conducted by GlaxoSmithKline showed many patients with systemic lupus erythematosus have difficulty describing symptoms and may minimize symptoms to physicians.The survey comprised 905 global respondents from the U.S., Brazil, Canada, France, Germany and Italy in 2014, including 200 patients with systemic lupus erythematosus (SLE), 100 caregivers and 75 physicians in the U.S., according to a press release.